The company is committed to improving the quality of life for people with serious and rare conditions by researching, developing, manufacturing, and marketing biotherapies. They focus on fulfilling their customers' needs, using the latest technologies to develop and deliver innovative therapies that treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. CSL Behring operates one of the world's largest plasma collection networks and delivers its life-saving therapies to people in over 100 countries.